Revelation Pharma Completes Two Acquisitions
Osceola Capital announced today the seventeenth and eighteenth additions to the Revelation Pharma (“Revelation” or the “Company”) platform, adding significant scale and capabilities to the business.
Uncategorized
Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference
Nevro Corp. today announced that 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT).
La importancia de los giroscopios: Un pilar fundamental en la navegación y la tecnología
Los giroscopios son dispositivos sorprendentes que desempeñan un papel crucial en una amplia gama de aplicaciones tecnológicas. Desde la navegación aeroespacial hasta los dispositivos móviles, estos ingeniosos instrumentos son utilizados para medir y mantener la orientaci …
La importancia de los giroscopios: Un pilar fundamental en la navegación y la tecnología Read More »
Quest Diagnostics Named a ‘Best Place to Work for Disability Inclusion’ for Sixth Consecutive Year
Quest Diagnostics announced it has been named to the 2023 Disability Equality Index® Best Places to Work for Disability Inclusion by Disability: IN and the American Association of People with Disabilities.
TheracosBio Announces Commercial Availability of Brenzavvy™ (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes
TheracosBio announced that Brenzavvy™, an FDA-approved oral sodium-glucose cotransporter 2 inhibitor, is now available by prescription through the Mark Cuban Cost Plus Drug Company, PBC.
The Caris Precision Oncology Alliance Welcomes The Broad Institute of MIT and Harvard
Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that the Broad Institute of MIT and Harvard has joined the Caris Precision Oncology Alliance™.
The Caris Precision Oncology Alliance Welcomes The Broad Institute of MIT and Harvard Read More »
¿Cuál es el límite de la velocidad humana en el atletismo?
Desde que el hombre comenzó a competir en carreras, hemos sido testigos de cómo los récords de velocidad en el atletismo han sido constantemente desafiados y superados. Desde las legendarias hazañas de Usain Bolt hasta las emocionantes competencias olímpicas, la b& …
¿Cuál es el límite de la velocidad humana en el atletismo? Read More »
Positive Results Announced from Phase 3 OCARINA II Trial Evaluating Roche’s OCREVUS® (ocrelizumab) with Halozyme’s ENHANZE® Drug Delivery Technology in Patients with Multiple Sclerosis
Halozyme Therapeutics, Inc. announced that Roche’s Phase 3 OCARINA II trial evaluating OCREVUS® with ENHANZE® as a twice a year 10-minute subcutaneous injection, met its primary and secondary endpoints in patients with relapsing forms of multiple sclerosis or primary progressive MS.
Discovery Of New Genetic Biomarkers May Pave The Way For A Lab Test For Bipolar Spectrum Disorder Within Three Years
A research team from The London Psychiatry Centre has discovered new genetic biomarkers in bipolar spectrum disorder.
Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab) Twice a Year, 10-Minute Subcutaneous Injection in Patients With Multiple Sclerosis
Genentech, a member of the Roche Group, announced that the Phase III OCARINA II trial evaluating Ocrevus® as a twice a year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with relapsing forms of MS or primary progressive MS.